ADMA Biologics, Inc. · 3 months ago
Regional Business Director - New York City
ADMA Biologics is a biopharmaceutical company dedicated to creating superior products for immunodeficient patients. They are seeking a Regional Business Director to manage sales planning and results for their products within the non-acute and acute market spaces, focusing on relationship-building and strategic planning within a designated region.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Individual contributor role accountable to the sales within a geographic region (own the dirt) through the interface with key medical providers and their staff as well as with specialty pharmacy partners and integrated health networks – driving sales of new and existing products
Manage the business within a specific geographical region through well-thought-out strategic planning, routing, and decision-making. Report directly to the Director of Sales of Sales
Being able to identify and engage the necessary and proper resources to win the business quickly
Compliantly educate physicians, staff, drug information review personnel, and pharmacy on the benefits of ADMA Biologics products
Establish, build, and maintain relationships as the liaison between all Accounts, the Specialty Distributors, and ADMA Biologics
Work with leadership on the selection of appropriate Accounts for targeting purposes; conduct SWOT analysis on new accounts, etc
Prepare monthly business reports on targeted accounts, current accounts, and status of relationship between Specialty Distributors and the Accounts. Make recommendations on ways to increase market share and/or make adjustments to changing market conditions
Maintain Customer database in CRM to include forecasting, run rates, growth potential trend analysis
Execute on the marketing strategy and create/maintain an updated regional business plan to maximize the business within your responsible business area; defining strategic imperatives, aligned strategies, and executional tactics
Establish and maintain relationships with Key Opinion Leaders (KOLs) and Healthcare Decision makers/influencers within the designated sales region
Consistently target, develop, maintain and sell to both new and existing customers and accounts
Attend local, regional, and national conferences on both disease state and product-specific topics
Qualification
Required
Must live in the Greater NYC area
Minimum of five (5) years' experience in pharmaceutical/biopharmaceutical sales or similar relevant sales
Ability to follow the cGMP's and procedures with great attention to detail
Ability to understand and interpret government regulations and customer specifications
Able to evaluate and interpret regulations and recognize the need for appropriate changes relative to procedures
Able to work in high-pressure, deadline-driven environment
Advanced knowledge of standard office software (Microsoft Office including Word, Excel, and Microsoft Project)
Exceptional Organizational And Communication Skills Required
FDA Adherence
Use independent judgment to assess compliance with regulatory requirements and SOPs
Preferred
Minimum of three (3) years of successful selling experience within the plasma biologics/specialty space strongly preferred
Minimum of two (2) years of experience in successful selling within the immunology space is preferred
Extensive knowledge of US Healthcare system and how it is structured and financed
Extensive knowledge of managed care systems, home care companies
Proficiency in technical aspects of ADMA Biologics product lines
Bachelor's degree in Business or Science. Advanced degree preferred
Benefits
401K plan with employer match and immediate vesting
Medical, Vision, Life and Dental Insurance
Pet Insurance
Company paid STD and LTD
Company Paid Holidays
3 Weeks’ Paid Time Off (within the first year)
Tuition Assistance (after the first year)
Easily accessible to Tri-Rail
Free shuttle to the Boca Tri-Rail station
Company
ADMA Biologics, Inc.
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.04BKey Investors
JP MorganAres ManagementHayfin Capital Management
2025-08-06Post Ipo Debt· $300M
2023-12-18Post Ipo Debt· $135M
2022-12-07Post Ipo Equity· $60M
Recent News
MarketScreener
2026-01-05
2025-11-07
Company data provided by crunchbase